News & Updates
Filter by Specialty:
Subcutaneous atezolizumab favoured over intravenous infusion
Nonsmall cell lung cancer (NSCLC) patients with high PD-L1 expression appear to show a strong preference for receiving atezolizumab subcutaneously rather than intravenously.
Subcutaneous atezolizumab favoured over intravenous infusion
02 Jul 2024Increasing trend in DOAC-related intracerebral haemorrhage: How to improve outcomes?
New local findings presented at HKMF 2024 show an increasing trend in intracerebral haemorrhage (ICH) among patients on direct oral anticoagulants (DOACs) between 2013 and 2022. Early initiation of reversal agents may improve outcomes in select cases with DOAC-related ICH.
Increasing trend in DOAC-related intracerebral haemorrhage: How to improve outcomes?
01 Jul 2024Legume intake reduces colorectal cancer risk
Eating legumes may help avert the development of colorectal cancer, according to a study that has found an inverse association between legume consumption and colorectal cancer risk.
Legume intake reduces colorectal cancer risk
30 Jun 2024Tobacco smoke exposure early in life ups paediatric IBD risk
A Scandinavian population-based birth cohort study reveals that children who were exposed to tobacco smoke during their early childhood have an increased risk of developing inflammatory bowel disease (IBD) later in life.